Shandong Xinhua Pharmaceutical Co (HKSE:00719) Short Interest


HKSE:00719 Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
92 GF Score
Price HK$6.08
GF Value HK$7.59
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:00719 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Xinhua Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Short Interest falls into.


HKSE:00719
92GF Score
Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shandong Xinhua Pharmaceutical Co (HKSE:00719) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of HK$6.08 is trading 19.9% below its estimated GF Value™ of HK$7.59. GuruFocus considers Shandong Xinhua Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for HKSE:00719:

  • Short Interest:
  • GF Value™: HK$7.59 vs. price of HK$6.08 (19.9% below fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00719 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Xinhua Pharmaceutical Co Business Description

Other Exchanges XIN:Germany000756:China
Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
92GF Score

Get the complete analysis for HKSE:00719

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.08
Price
HK$7.59
GF Value